Target intelligence / Profile preview

RN7SK pseudogene 100 (RN7SKP100)

Target
RN7SKP100
Molecular classification
Other (Pseudogene)
01

Overview

RN7SK pseudogene 100 (RN7SKP100) is classified as a pseudogene, specifically a non-coding RNA sequence that closely resembles the functional RN7SK gene but is not transcribed into functional RNA or protein products[4]. Pseudogenes like RN7SKP100 do not encode biologically active molecules and are not known to have direct biological functions, disease associations, or roles as drug targets. The functional paralog, RN7SK (RNA, 7SK small nuclear), forms the RNA component of the 7SK small nuclear ribonucleoprotein (7SK snRNP) involved in regulating transcription elongation by RNA polymerase II[1][2][3][5]. However, RN7SKP100 itself has no documented biological function, is not a therapeutic target, and is best categorized as a genomic relic without clinical or pharmacological relevance[4].\n\nKey points:\n- RN7SKP100 is a putative pseudogene and not an active molecular target.\n- Confusion is possible due to its similarity to RN7SK, which does have important regulatory roles[3][4][5].\n- There are no drugs, clinical biomarkers, or therapies associated with RN7SKP100, nor are there documented safety or disease roles.\n\nIf you require information on the functional form RN7SK, further details on its molecular and biological activity are available.

Other names
RN7SKP100RNA, 7SK small nuclear pseudogene 100

Beyond the preview

Go deeper on RN7SK pseudogene 100 (RN7SKP100).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RN7SK pseudogene 100 (RN7SKP100).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call